Inventor · disambiguated record
Sheldon Cao
Also filed as: CAO SHELDON · CAO SHELDON X · CAO SHELDON XIAODONG
21 granted patents·15 pending applications·176 citations·filing 2002–2022
94Inventor score
Files withTAKEDA SAN DIEGO INC8EUBULUS BIOTHERAPEUTICS INC5AGIOS PHARMACEUTICALS INC4TAKEDA PHARMACEUTICAL4CAO SHELDON2
Top patents by PatentIndex Score
36 records- 0195US7154002B1Histone deacetylase inhibitorsTAKEDA SAN DIEGO INC·Filed 2003·Granted Dec 26, 2006·51 cites·119 claims
- 0291US9108921B2Therapeutic compounds and compositionsCIANCHETTA GIOVANNI·Filed 2014·Granted Aug 18, 2015·22 cites·8 claims
- 0391US7169801B2Histone deacetylase inhibitorsTAKEDA SAN DIEGO INC·Filed 2004·Granted Jan 30, 2007·34 cites·67 claims
- 0488US7759339B2Hydroxysteroid dehydrogenase inhibitorsTAKEDA SAN DIEGO INC·Filed 2006·Granted Jul 20, 2010·22 cites·33 claims
- 0586US8008332B2Substituted indazoles as glucokinase activatorsTAKEDA SAN DIEGO INC·Filed 2007·Granted Aug 30, 2011·9 cites·49 claims
- 0683US8318727B2Polo-like kinase inhibitorsCAO SHELDON X·Filed 2010·Granted Nov 27, 2012·13 cites·13 claims
- 0779US7381825B2Histone deacetylase inhibitorsTAKEDA SAN DIEGO INC·Filed 2004·Granted Jun 3, 2008·9 cites·33 claims
- 0877US9856279B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·1 cites·26 claims
- 0975US7399884B2Histone deacetylase inhibitorsTAKEDA SAN DIEGO INC·Filed 2006·Granted Jul 15, 2008·1 cites·56 claims
- 1075US7375228B2Histone deacetylase inhibitorsTAKEDA SAN DIEGO INC·Filed 2004·Granted May 20, 2008·6 cites·63 claims
- 1169US9662327B2Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancerCAO SHELDON·Filed 2012·Granted May 30, 2017·2 cites·22 claims
- 1269US7790734B2Dipeptidyl peptidase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2004·Granted Sep 7, 2010·4 cites·95 claims
- 1365US10000479B2Compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jun 19, 2018·1 cites·25 claims
- 1460US8124617B2Imidazopyridine compoundsIWATA HIDEHISA·Filed 2006·Granted Feb 28, 2012·1 cites·3 claims
- 1557US2005159470A1Histone deacetylase inhibitorsSYRRX INC·Filed 2004·Application pending·0 cites
- 1655US2025041306A1Targeted protease degradation (ted) platformEUBULUS BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1754US2016046579A1Therapeutic compounds and compositionsCIANCHETTA GIOVANNI·Filed 2014·Application pending·0 cites
- 1852US9365545B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jun 14, 2016·0 cites·31 claims
- 1952US2010075973A1Polo-like kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 2050US2009291938A1Polo-like kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 2149US2007197532A1Glucokinase activatorsCAO SHELDON X·Filed 2006·Application pending·0 cites
- 2248US11998534B2GPX4 inhibitor in combination with anticancer agent for treating proliferative diseaseEUBULUS BIOTHERAPEUTICS INC·Filed 2021·Granted Jun 4, 2024·0 cites·17 claims
- 2348US2011301155A1Indazole compounds for activating glucokinaseYASUMA TSUNEO·Filed 2008·Application pending·0 cites
- 2448US2017210749A1Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2547US2024101546A1Heteroaryl-acetylenes, pharmaceutical compositions thereof, and their therapeutic applicationsEUBULUS BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2645US8394843B2Substituted isoindoles as glucokinase activatorsFENG JUN·Filed 2011·Granted Mar 12, 2013·0 cites·20 claims
- 2745US2003187007A1Inhibitors of protein kinase for the treatment of diseaseFiled 2002·Application pending·0 cites
- 2844US2011070297A1Glucokinase activatorsTAKEDA SAN DIEGO INC·Filed 2010·Application pending·0 cites
- 2943US2003208067A1Inhibitors of protein kinase for the treatment of diseaseFiled 2002·Application pending·0 cites
- 3043US2023210999A1Targeted protease degradation (ted) platformEUBULUS BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3143US2014213580A1Therapeutically active compositions and their methods of useCAO SHELDON·Filed 2012·Application pending·0 cites
- 3242US11679162B2Anti-5T4 antibody-drug conjugate and use thereofHANGZHOU ADCORIS BIOPHARMA CO LTD·Filed 2018·Granted Jun 20, 2023·0 cites·20 claims
- 3342US2021369853A1Targeted protease degradation platformEUBULUS BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3440US7550598B2Kinase inhibitorsTAKEDA PHARMACEUTICAL·Filed 2005·Granted Jun 23, 2009·0 cites·47 claims
- 3537US12318455B2Anti-HER2 antibody-drug conjugate and application thereofHANGZHOU ADCORIS BIOPHARMA CO LTD·Filed 2017·Granted Jun 3, 2025·0 cites·14 claims
- 3630US9920022B2Small molecule compound and synthesizing method and uses thereofTECHNODERMA MEDICINES PTE LTD·Filed 2017·Granted Mar 20, 2018·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Sheldon Cao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →